Venture Partners
Our Venture Partners help shape educational program development and participate as speakers and moderators at Biodesign events. Venture Partners may also assist with market evaluation and technology assessment as well as providing contacts and resources for development/incubation of new technologies. For more information about the Biodesign Venture Partners Program, please contact Christine Kurihara at (650) 736-1160 or by email: christine.kurihara@stanford.edu
- Advanced Technology Ventures
- Alloy Ventures
- Artiman Ventures
- Delphi Ventures
- De Novo Ventures
- Frazier Healthcare
- InterWest Partners
- Kearny Venture Partners
- Kleiner Perkins Caufield & Byers
- Montreux Equity Partners
- Mohr Davidow Ventures
- New Enterprise Associate
- ONSET Ventures
- Prospect Venture Partners
- Sanderling
- Split Rock Partners
- Three Arch Partners
- U S Venture Partners
- Versant Ventures
- Profile:
- Founded in 1979, Advanced Technology Ventures (ATV) is a bi-coastal venture capital firm with more than $1.4 billion in capital under management. We work closely with entrepreneurial teams in several technology markets, including communications, infrastructure, software and services, consumer technology, biopharmaceuticals, medical devices and emerging technologies, to build emerging-growth business ventures into market leaders. With more than 25 years of experience, ATV has a proven track record of success in helping to build strong, sustainable business enterprises.
- Contact Advanced Technology Ventures:
- 485 Ramona
Street, Palo Alto, CA 94301
650.321.8601
Michael Carusi
- Profile:
- Alloy Ventures partners have decades of investment experience in the information technology and health care industries. Some of Alloy's successes include Remedy, Amgen, Pharmacyclics, Archive (CONNER), Applied Biosystems (PE Biosystems), Octel (Lucent), InPart (Parametric), and Sapient (Healtheon/WebMD). Whether you are honing strategy, hiring a team, seeking partnerships, or raising additional funds, Alloy offers you the experience, connections, and capital you need to transform brilliant ideas into winning companies.
- Contact Alloy Ventures:
- 480 Cowper Street, Palo Alto, CA 94301
650.687.5000
Douglas Kelly, MD
Craig Taylor
- Profile:
- At Artiman Ventures, we focus our energies on helping talented entrepreneurs commercialize leading edge technologies to create world class companies. We are actively involved with our entrepreneurs from the earliest stages of company creation in distilling ideas and opportunities, brainstorming, refining business plans, building high energy teams, developing channel partners and customers, and syndicating venture financings.
- Contact Artiman Ventures:
- 2000 University Ave, Suite 602, East Palo Alto, CA 94303
650.845.2020
Amit Shah
Saurabh Srivastava
Yatin Mundkur
- Profile:
- The partners at Delphi Ventures help build healthcare companies. Delphi has been
the lead or co-lead investor in more than 75% of its investments. Delphi prefers
to be active in its investments, taking Board seats and working closely with
our companies' management teams. We provide capital, contacts and leadership.
While most of our investments are in the western U.S., we are willing to invest
anywhere in the U.S. under the proper circumstances. Delphi focuses its
investments on medical devices and diagnostics, biotechnology, and healthcare
services
- Contact Delphi Ventures:
- 3000 Sand Hill Road,
Building 1, Suite 135, Menlo Park, CA 94025
650.854.9650
David Douglass John Maroney
- Profile:
- De Novo Ventures, founded in 2000, invests in early stage
life science companies that focus on therapeutic medical devices
and biotechnology. These include emerging device opportunities
in cardiology, neurology, ophthalmology, orthopedics, plastics,
gastroenterology, pulmonology, and biotech companies with initial
human clinical experience. De Novo has $350 million under management
and its portfolio includes over 20 medical device and biotechnology
compan ies. Located in Palo Alto, California, the firm invests
nationally with a focus on the Western US. De Novo Ventures
is highly regarded among active entrepreneurs because of its
team's significant operating and investment experience. As
entrepreneurs, the fund managers personally have founded or
co-founded 10 companies including Advanced Cardiovascular Systems,
CardioThoracic Systems, Origin Medsystems, Gynecare, and Perclose.
De Novo Ventures encourages young companies to take a look at
the substantial impact that its team can have on their businesses.
- Contact De Novo Ventures:
- 400 Hamilton Ave, Suite 300, Palo Alto, CA 94301
650.329.1999
Kathryn Cavanaugh
Frederick Dotzer
Richard Ferrari
Joe Mandato
David Mauney, MD
Jay Watkins
- Profile:
- Frazier Healthcare was founded in 1991 by Alan Frazier, the former executive vice president and chief financial officer of Immunex Corporation. Since then Frazier Healthcare has raised more than $750 million through five funds and has invested in more than 75 promising healthcare companies. We mainly focus on the biopharma and medical device sectors, with select investments in healthcare services companies. Frazier Healthcare has backed some of the most successful companies in healthcare. And our active portfolio includes many companies that hold the promise of being the industry leaders of the future. Since our inception, 19 of the companies we have backed have gone public and many others have been successfully acquired.
- Contact Frazier Healthcare Ventures:
- 550 Hamilton Avenue, Suite 100, Palo Alto, CA 94301
650.325.5156
Sam Brasch
Nathan Every, MD
Alan Frazier
Trevor Moody
- Profile:
- InterWest invests an average of about 5 million
dollars over the span of our involvement with each company in our
portfolio. We invest in companies through the full range of venture
investment stages, and investments may be staged over several rounds
of financing. Although we generally begin our involvement in the
early stages of a company's development, we pursue attractive
opportunities based on their individual merits rather than their
investment stage. InterWest is the lead investor in more than
70-percent of the investments we make, reflecting our ability to
marshal resources and organize financings on behalf of our portfolio
companies. We maintain relationships with our portfolio companies for
an average of 4 years and in some cases for 10 years or more. An
InterWest general partner serves as a director for 85-percent of the
companies in our portfolio, often continuing to serve even after the
partnership's investment in the company has been returned. This high
level of personal commitment enables us to deliver on our fundamental
promise to the entrepreneurs we back: to add value beyond the capital
we contribute.
- Contact Interwest Partners:
- 3000 Sand Hill Rd., Building 3, Suite #225, Menlo Park, CA 94025
650.854.8585
Chris Ehrlich
Nina Kjellson - Gilbert
Kliman, MD
Ellen Koskinas
Dr. Arnold Oronsky
Michael Sweeney
- Profile:
- With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. We believe that the opportunity for entrepreneurs to devise innovative solutions in healthcare has never been greater. Significant unmet needs in healthcare continue to persist, representing large potential market opportunities for safe and effective products. As the molecular basis of disease is increasingly unraveled, new opportunities for intervention emerge. Novel therapies can and will displace incumbent products.
- Contact Kearny Venture Partners:
- 88 Kearny Street, 5th Floor, San Francisco, CA 94108-5530
415.364.5999
Jim Shapiro
- Profile:
- In 1972, KPCB began offering entrepreneurs a broader philosophy of value-added investing: not merely access to capital, but access to people. A partnership with experienced industry leaders who recognize, challenge, and even improve on a brilliant idea. We believe that we must earn the right to advise entrepreneurs on a daily basis, by intellectually committing to deliver the best ideas of which we are capable. We are here to build on your vision. Strengthen strategic thinking. Tap the industry network. Access talent. Pull strings. Sew up financing. And stick with you through every challenge along the way.
- Contact Kleiner Perkins:
- 2750 Sand Hill Road Menlo Park CA 94025
650.233.2750
Brook Byers
Joseph Lacob
Dana Mead, PhD
Risa Stack
- Profile:
- MDV invests in innovative entrepreneurs with deep expertise in energy and materials, Internet services; life sciences, semiconductor and software and systems. Our venture capital team engages very early in the life of a company to impact its long-term success. We apply years of real-world experience to accelerate each company's time to market and optimize its success.
For more than 20 years, our mission as an early stage venture capital firm has been to identify, invest in, mentor and develop venture-backed companies that redefine how organizations and individuals apply new technologies and scientific advances. - Contact Mohr Davidow Ventures:
- 3000 Sand Hill Road, Bldg 3, Suite 290, Menlo Park, CA 94025
650-854-7236
- Rowan Chapman
Bill Ericson
Michael Goldberg - Rowan Chapman
- Profile:
- Founded in 1993, Montreux Equity Partners, based in Menlo Park, CA, is a li
fe sciences focused venture capital firm that invests in new and emerging pharma
ceutical, biopharmaceutical and medical device companies that bring important th
erapeutic benefits to patients and their physicians.
Montreux has over $ 170 million under management and is currently investing out of funds with over $ 150 million in capital. Montreux investment ranges from $2-$5 million in any giv en financing and up to $10 million over the life cycle of the investment. - Contact Montreux Equity Partners:
- 2500 Sand Hill Rd., #215 Menlo Park CA 94025
650.234.1200
- Manesh Chapekar
Howard Palefsky
John Savarese, MD
Daniel Turner - Manesh Chapekar
- Profile:
- New Enterprise Associates (NEA) is one of the industry's premier venture capital firms. For 21 years, NEA has practiced classic venture capital by investing in early-stage companies and working with management to nurture and build companies of real and lasting value. NEA is now the leading start-up venture investor in the country. NEA shares characteristics with other venture firms but differs in many ways: its size and scope, the number of successful companies it has financed, its geographic reach, the experience and expertise of its partners and its commitment to its entrepreneurs and their companies. Since inception in 1978, more than 100 NEA companies have gone public; more than 60 since 1991.
- Contact NEA:
- 2490 Sand Hill Road Menlo Park, CA 94025
650.854.9499
Robert Garland, MD
Robert "Chip" Linehan
Mohamad Makhzoumi
Josh Makower, MD
Michael Raab
Christopher Shen, MD
Sigrid VanBladel
- Profile:
- ONSET Ventures is a 20-year-old venture capital firm specializing in information and medical technology-based start-ups that has pioneered a shirt-sleeves style of active collaboration with entrepreneurs, to conceive and develop sustainable businesses of significant value.
We've backed nearly 100 companies since 1984, focusing on early-stage and select later stage enterprises in business-to-business markets. Today, we have more than $700 million under management, and an enviable track record: over 80% of ONSET investments have gone on to achieve successive levels of financing, significantly higher than the industry at large. - Contact Onset Ventures:
- 2490 Sand Hill Road, Menlo Park, California 94025
650.529.0700
Leslie Bottorff
Ken Martin
- Profile:
- Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1 billion of capital under management. The firm is dedicated to investing in outstanding biomedical technology and life science companies. Prospect targets commercially attractive health care enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technology or services with potential for significant investment returns. The firm invests in companies with a broad range of development and financing requirements including: (a) incubating new companies, (b) investing in first and second venture financing rounds, and (c) participating in later stage private and public companies with proven business models requiring expansion capital.
Prospect Venture Partners seeks to ultimately invest $10-20 million in each company in its portfolio, typically as a lead investor or as a co-lead in an investor syndicate. First round investments most often range from $500,000 to $10 million. Prospect Venture Partners typically has representation on the board of directors for each of its portfolio companies.
- Contact Prospect Venture Partners:
- 435 Tasso Street, Suite 200, Palo Alto, CA 94301
650.327.8800
Scott Wolf, M.D.
- Profile:
- Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. Sanderling's unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates-of-return for both its entrepreneurs and investors.
Sanderling emphasizes early-stage financing and active management of its portfolio companies. Sanderling and its principals play an active role in new ventures by providing seed and early-stage funding, contributing management leadership and administrative support, developing cost-control strategies to extend availabl e dollars, supplying technical and regulatory expertise where needed, and offering the insight and perspective of those who have "done it before." The Partners hip has sufficient capital to support the companies in later-stage financing, protecting its investments from excessive dilution. - Contact Sanderling:
- 400 S. El Camino Real, Suite 1200, San Mateo, CA 94402
650.401.2000
Tim Mills, PhD
- Profile:
- Split Rock Partners, with offices in Minneapolis and Menlo Park, seeks engagement with entrepreneurs and co-investors who share our zeal for emerging opportunities in healthcare and software, and our determination to transform those opportunities into thriving businesses. In healthcare, we specialize in medical device and specialty pharmaceutical opportunities. In software and services, we focus on enterprise software and business and consumer services. Our primary geographic focus is on companies based in the Upper Midwest and West Coast. We are active venture investors in the sectors we target. The investment professionals at Split Rock Partners collectively have more than 80 years of venture investing and company-building experience. Between our four partners, we have founded or co-founded 13 companies and held CEO roles in 8 start-up companies. We focus on working with entrepreneurs collaboratively, building partnerships with them based on integrity and mutual respect, and working together to nurture promising ideas into successful companies. Additional information about the firm can be found at www.splitrockpartners.com.
- Contact Split Rock Partners:
- 1600 El Camino Real, Suite 290, Menlo Park CA 94025
650.617.1500
Allan Will
Josh Baltzell
- Profile:
- Three Arch Partners was formed to fund early stage opportunities. Our strategy is to invest primarily in startups. We attempt to help identify and understand the important technical, regulatory, intellectual property and market issues. We concentrate exclusively on life science companies, with a particular emphasis on medical devices and healthcare services. Three Arch forms new companies where there are significant medical markets and unmet clinical needs. As often, the fund assists physicians and inventors in establishing companies. Our involvement may include securing capital, assembling management, technical, and regulatory teams, and providing interim operational support. While our primary interest is in early stage investing, we will consider selected opportunities in later stage healthcare companies that can benefit from our experience and resources, and which promise strong financial returns.
- Contact Three Arch Partners:
- 3200 Alpine Road, Portola Valley, CA 94028
650.529.8000
Bill Harrington
Wilfred Jaeger, MD
Michael Kaplan
Richard Lin, MD
Mark Wan
- Profile:
- U.S. Venture Partners is a venture capital management Firm that invests pri marily in early stage technology, medical, and consumer companies. USVP's objec tive is to finance, and help to build well-managed enterprises of significant va lue in its targeted industry sectors. The Firm seeks people with skills, experie nce, vision, energy and persistence, and is proactive in supporting the entrepre neurs in the identification and achievement of their business objectives. USVP is one of the larger and more prominent venture capital firms on the West Coast. With the significant record of extensive direct operating experience of its partners and as a lead early round investor in many successful companies, the Firm has the ability to provide capital, counsel, financial and management expertise and access through a broad network of relationships.
- Contact USVP:
- 2735 Sand Hill Road, Menlo Park, CA 94025
650.854.9080
- Alan Kaganov, ScD
Jonathan Root, MD
Phil Young - Alan Kaganov, ScD
- Profile:
- Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in 1999, consists of a seasoned team of twelve managing directors with more than 130 years of venture capital investing experience and more than 150 years of operating experience.
-
Versant Ventures currently manages over $1 billion in committed capital having recently raised its third fund in November 2005, and is currently managing over 75 companies in its portfolio.
- Contact Versant Ventures:
- 3000 Sand Hill Road, Bldg.4, Suite 210, Menlo Park,
CA 94025
650.233.7877
Ross Jaffe, MD
Beckie Robertson
Kevin Wasserstein